Oncology Clinical Trials in Webster, TX
As of August 2026, 20 paid clinical trials are recruiting for Oncology in Webster, Texas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
20 clinical trials for Oncology
·Clear filters·Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
Top Research Study Locations in Webster
Researchers run research studies in Webster, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Texas Oncology - Gulf Coast | Advanced Non-Small Cell Lung Cancer, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 9 |
| Tranquil Clinical Research | Breast Cancer, Breast Cancer Metastatic, Breast Neoplasm | 5 |
| Center for Clinical Studies | Atopic Dermatitis, Moderate to Severe Glabellar Lines, Overweight or Obesity | 4 |
| GI Alliance - Webster | Crohn's Disease, Ulcerative Colitis | 3 |
| Tranquil Research | Colorectal Cancer, Myelodysplastic Syndromes, Sjogren Disease | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Center for Clinical Studies, LTD. LLP | Herpes Zoster (HZ), Nodular Basal Cell Carcinoma, Superficial Basal Cell Carcinoma | 2 |
| GI Alliance-Webster | Constipation, Irritable Bowel Syndrome, Ulcerative Colitis | 2 |
| Shady Grove Houston | In Vitro Maturation of Oocytes, Infertility (IVF Patients) | 2 |
| TDDC GI Alliance research Webster | Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis | 2 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Center for Clinical Studies - Clear Lake | Alopecia Areata | 1 |
| Center for Clinical Studies at Webster Clear Lake | Cutaneous Squamous Cell Carcinoma (CSCC) | 1 |
| Clinical Study Site | Non-Small Cell Lung Cancer | 1 |
| Cullinan Investigative Site | Immune Thrombocytopenia (ITP), Warm Autoimmune Hemolytic Anemia (WAIHA) | 1 |
| GSK Investigational Site | Pulmonary Disease, Chronic Obstructive | 1 |
| Grifols Investigative site | Hepatitis B Virus Infection | 1 |
| Houston Physicians Hospital | Lumbar Spinal Stenosis | 1 |
| Houston Skin | Onychomycosis of Toenail | 1 |
| Investigative | Hidradenitis Suppurativa (HS) | 1 |
| Mirador Therapeutics Selected Site | Crohn's Disease, Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC) | 1 |
| Oruka Therapeutics Investigative Site | Plaque Psoriasis | 1 |
| Renovatio Clinical | Idiopathic Pulmonary Fibrosis (IPF) | 1 |
| Texas Oncology - Deke Slayton Cancer Center | Metastatic Colorectal Cancer | 1 |
| Texas Oncology - Gulf Coast (SCRI) | Gastric Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer | 1 |
Active & Upcoming Studies in Webster (2026)
Recruiting trials in Webster grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (24 active studies)
- Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma · Phase 3 · Immuneering Corporation
- Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer · Phase 1, Phase 2 · Pfizer
Diabetes & metabolic (3 active studies)
- A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO) · Phase 4 · Eli Lilly and Company
- A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH · Phase 3 · Akero Therapeutics, Inc
HIV / STI (1 active study)
Cardiovascular (1 active study)
Common conditions studied in Webster
- Ulcerative Colitis (4 active studies)
- Carcinoma, Non-Small-Cell Lung (3 active studies)
- Crohn's Disease (3 active studies)
- Neoplasm Metastasis (3 active studies)
- Breast Cancer (2 active studies)
- Gastroesophageal Junction Adenocarcinoma (2 active studies)
Leading research sponsors in Webster
- Eli Lilly and Company
- Pfizer
- Takeda
- Cullinan Therapeutics Inc.
- Hoffmann-La Roche
Frequently asked questions
How many paid clinical trials are currently recruiting in Webster?
There are approximately 62 recruiting clinical trials in Webster, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Webster pay participants?
Most recruiting trials in Webster compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Webster?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Webster?
The most common conditions under active study in Webster include Ulcerative Colitis (4), Carcinoma, Non-Small-Cell Lung (3), Crohn's Disease (3), Neoplasm Metastasis (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Webster?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Webster on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Webster?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Webster?
Recruiting research sites in Webster include Texas Oncology - Gulf Coast, Tranquil Clinical Research, Center for Clinical Studies, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Webster right now?
The largest active categories in Webster are Cancer & tumors (24), Diabetes & metabolic (3), HIV / STI (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.